|
Name |
3-Hydroxy-4-phenylbutan-2-one
|
Molecular Formula | C10H12O2 | |
IUPAC Name* |
3-hydroxy-4-phenylbutan-2-one
|
|
SMILES |
CC(=O)C(CC1=CC=CC=C1)O
|
|
InChI |
InChI=1S/C10H12O2/c1-8(11)10(12)7-9-5-3-2-4-6-9/h2-6,10,12H,7H2,1H3
|
|
InChIKey |
QBCUUJGHWFKMDC-UHFFFAOYSA-N
|
|
Synonyms |
3-hydroxy-4-phenylbutan-2-one; 5355-63-5; 3-HYDROXY-4-PHENYL-2-BUTANONE; 2-Butanone, 3-hydroxy-4-phenyl-; 4-Phenyl-3-hydroxybutan-2-one; FEMA no. 4052; 3-Hydroxy-4-phenylbutan-2-one [FHFI]; EP0R730B2H; 2-Butanone, 3-hydroxy-4-phenyl; UNII-EP0R730B2H; SCHEMBL105702; DTXSID20968310; CHEBI:180403; Q27277276
|
|
CAS | 5355-63-5 | |
PubChem CID | 6428929 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 164.2 | ALogp: | 1.3 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.737 |
Caco-2 Permeability: | -4.321 | MDCK Permeability: | 0.00003000 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.056 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.192 | Plasma Protein Binding (PPB): | 57.72% |
Volume Distribution (VD): | 0.819 | Fu: | 44.65% |
CYP1A2-inhibitor: | 0.224 | CYP1A2-substrate: | 0.608 |
CYP2C19-inhibitor: | 0.177 | CYP2C19-substrate: | 0.385 |
CYP2C9-inhibitor: | 0.031 | CYP2C9-substrate: | 0.221 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.567 |
CYP3A4-inhibitor: | 0.008 | CYP3A4-substrate: | 0.467 |
Clearance (CL): | 11.782 | Half-life (T1/2): | 0.883 |
hERG Blockers: | 0.035 | Human Hepatotoxicity (H-HT): | 0.342 |
Drug-inuced Liver Injury (DILI): | 0.419 | AMES Toxicity: | 0.041 |
Rat Oral Acute Toxicity: | 0.076 | Maximum Recommended Daily Dose: | 0.04 |
Skin Sensitization: | 0.419 | Carcinogencity: | 0.136 |
Eye Corrosion: | 0.332 | Eye Irritation: | 0.976 |
Respiratory Toxicity: | 0.038 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000130 | 0.610 | D0R1CR | 0.610 | ||||
ENC000218 | 0.605 | D0T3LF | 0.564 | ||||
ENC000717 | 0.574 | D05BMG | 0.564 | ||||
ENC000054 | 0.564 | D0P6UB | 0.524 | ||||
ENC000308 | 0.561 | D05OIS | 0.514 | ||||
ENC001005 | 0.561 | D0P2GK | 0.447 | ||||
ENC004815 | 0.532 | D0S2UG | 0.440 | ||||
ENC000219 | 0.525 | D07ONP | 0.438 | ||||
ENC005854 | 0.525 | D0U0RZ | 0.432 | ||||
ENC000208 | 0.524 | D0J2MJ | 0.431 |